Autosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid Progression.
CONCLUSIONS: The ERA-EDTA WGIKD/ERBP algorithm provides a valuable means of identifying in routine clinical practice patients who may be eligible for treatment with tolvaptan. The impact of a new threshold for age and eGFR may increase the percentage of patients to be treated.
PMID: 30347391 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Furlano M, Loscos I, Martà T, Bullich G, Ayasreh N, Rius A, Roca L, BallarÃn J, Ars E, Torra R Tags: Am J Nephrol Source Type: research
More News: Dialysis | Genetics | History of Medicine | Kidney Transplant | Kidney Transplantation | Polycystic Kidney Disease | Study | Transplant Surgery | Transplants | Ultrasound | Urology & Nephrology